| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3332128 | Hematology/Oncology Clinics of North America | 2008 | 19 Pages |
Abstract
The role of radiotherapy for patients who have thymic neoplasms remains unclear. The low incidence of thymic malignancies, excellent outcome with complete resection, and limited body of evidence obfuscate the role of radiation therapy within the current multidisciplinary management of disease. Nonetheless, existing literature reports and novel radiotherapy techniques show increasing potential for integration of radiotherapy into the standard therapeutic milieu for carefully selected patient subpopulations.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Clifton David Fuller, Douglas M. Housman, Charles R. Thomas,